Market Challenges: Side Effects and Alternatives
While ACE inhibitors are effective, side effects such as persistent cough and hyperkalemia sometimes limit their use. This has led to the rise of alternative therapies like ARBs, which offer similar benefits with fewer adverse effects. These alternatives pose a competitive challenge to the ACE Inhibitors Market.
To remain competitive, companies are innovating with novel formulations and combination products to improve tolerability. Continued education on managing side effects also plays a role in sustaining patient retention and market demand.